Sourav Sinha Photo

Sourav Sinha

Founder, CEO, Oncolinx

Boston

Sourav Sinha is the Founder and CEO of Oncolinx-- an early-stage bio-oncology company developing targeted cancer therapies that avoid many of the adverse side-effects of current treatments. Oncolinx is partnered with more than 14 leading pharmaceutical companies and was named a winner of the 2014 MassChallenge startup accelerator.

Sourav is also the Entrepreneur In Residence of Gazelle Futures--a first-of-its-kind venture fund to spin out the best inventions from the NIH, NASA, DoD, DARPA, and other government funded agencies.

The World Economic Forum named Sourav as a Young Global Shaper. Sourav was also named as a top 50 global entrepreneur under the age of 25 by Inc. Magazine. Sourav has been published in top scientific journals and holds 1 patent. Sourav holds a AB from Dartmouth College in Molecular Biology and Biochemistry, and an MA in Biomedical Sciences from Rutgers Biomedical Health Sciences.

Upcoming Courses

Previously (1)

Want to teach at ga?

Join our global community of instructors and help shape the next generation of industry leaders — while moving your own career forward with proven subject matter expertise, leadership experience, and public speaking skills. Teach online or on campus, full-time
or part-time.

Learn More